nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—SLC22A2—Vinblastine—head and neck cancer	0.214	0.522	CbGbCtD
Epinephrine—CYP1A2—Fluorouracil—head and neck cancer	0.0704	0.172	CbGbCtD
Epinephrine—CYP2C9—Fluorouracil—head and neck cancer	0.0634	0.155	CbGbCtD
Epinephrine—CYP3A4—Vinblastine—head and neck cancer	0.0341	0.0833	CbGbCtD
Epinephrine—CYP3A4—Docetaxel—head and neck cancer	0.0281	0.0686	CbGbCtD
Epinephrine—Ischaemia—Vinblastine—head and neck cancer	0.0165	0.0743	CcSEcCtD
Epinephrine—Skin necrosis—Hydroxyurea—head and neck cancer	0.0157	0.0708	CcSEcCtD
Epinephrine—Isoprenaline—MAPK1—head and neck cancer	0.0103	0.823	CrCbGaD
Epinephrine—Local reaction—Fluorouracil—head and neck cancer	0.00715	0.0322	CcSEcCtD
Epinephrine—Extravasation—Vinblastine—head and neck cancer	0.00691	0.0311	CcSEcCtD
Epinephrine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00525	0.0236	CcSEcCtD
Epinephrine—Necrosis—Fluorouracil—head and neck cancer	0.00505	0.0227	CcSEcCtD
Epinephrine—Tingling sensation—Fluorouracil—head and neck cancer	0.00493	0.0221	CcSEcCtD
Epinephrine—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00493	0.0221	CcSEcCtD
Epinephrine—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0049	0.022	CcSEcCtD
Epinephrine—Extravasation—Fluorouracil—head and neck cancer	0.00454	0.0204	CcSEcCtD
Epinephrine—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00447	0.0201	CcSEcCtD
Epinephrine—Disorientation—Hydroxyurea—head and neck cancer	0.00446	0.0201	CcSEcCtD
Epinephrine—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.00436	0.0196	CcSEcCtD
Epinephrine—Necrosis—Docetaxel—head and neck cancer	0.00364	0.0164	CcSEcCtD
Epinephrine—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00356	0.016	CcSEcCtD
Epinephrine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00333	0.015	CcSEcCtD
Epinephrine—Myocardial infarction—Vinblastine—head and neck cancer	0.00331	0.0149	CcSEcCtD
Epinephrine—Extravasation—Docetaxel—head and neck cancer	0.00328	0.0147	CcSEcCtD
Epinephrine—Disorientation—Fluorouracil—head and neck cancer	0.00321	0.0144	CcSEcCtD
Epinephrine—Drug interaction—Docetaxel—head and neck cancer	0.00308	0.0139	CcSEcCtD
Epinephrine—Drowsiness—Hydroxyurea—head and neck cancer	0.00308	0.0138	CcSEcCtD
Epinephrine—Haemoglobin—Vinblastine—head and neck cancer	0.00305	0.0137	CcSEcCtD
Epinephrine—Haemorrhage—Vinblastine—head and neck cancer	0.00303	0.0136	CcSEcCtD
Epinephrine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00301	0.0136	CcSEcCtD
Epinephrine—Blood pressure increased—Docetaxel—head and neck cancer	0.00286	0.0129	CcSEcCtD
Epinephrine—Haemoglobin—Hydroxyurea—head and neck cancer	0.00278	0.0125	CcSEcCtD
Epinephrine—Haemorrhage—Hydroxyurea—head and neck cancer	0.00276	0.0124	CcSEcCtD
Epinephrine—Hallucination—Hydroxyurea—head and neck cancer	0.00275	0.0124	CcSEcCtD
Epinephrine—Skin exfoliation—Docetaxel—head and neck cancer	0.00273	0.0123	CcSEcCtD
Epinephrine—Lightheadedness—Docetaxel—head and neck cancer	0.00256	0.0115	CcSEcCtD
Epinephrine—Pulmonary oedema—Docetaxel—head and neck cancer	0.00254	0.0114	CcSEcCtD
Epinephrine—Erythema—Hydroxyurea—head and neck cancer	0.00241	0.0108	CcSEcCtD
Epinephrine—Hypertension—Vinblastine—head and neck cancer	0.00228	0.0102	CcSEcCtD
Epinephrine—Isoprenaline—CYP1A1—head and neck cancer	0.00221	0.177	CrCbGaD
Epinephrine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00218	0.00982	CcSEcCtD
Epinephrine—Renal impairment—Docetaxel—head and neck cancer	0.00218	0.0098	CcSEcCtD
Epinephrine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00217	0.00976	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00203	0.00914	CcSEcCtD
Epinephrine—Haemoglobin—Fluorouracil—head and neck cancer	0.002	0.00899	CcSEcCtD
Epinephrine—Haemorrhage—Fluorouracil—head and neck cancer	0.00199	0.00894	CcSEcCtD
Epinephrine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00198	0.0089	CcSEcCtD
Epinephrine—Paraesthesia—Vinblastine—head and neck cancer	0.00193	0.00869	CcSEcCtD
Epinephrine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00193	0.00865	CcSEcCtD
Epinephrine—Skin disorder—Hydroxyurea—head and neck cancer	0.00191	0.00857	CcSEcCtD
Epinephrine—Arrhythmia—Fluorouracil—head and neck cancer	0.00178	0.00799	CcSEcCtD
Epinephrine—Somnolence—Hydroxyurea—head and neck cancer	0.00175	0.00785	CcSEcCtD
Epinephrine—Erythema—Fluorouracil—head and neck cancer	0.00173	0.00778	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00169	0.00762	CcSEcCtD
Epinephrine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00158	0.00709	CcSEcCtD
Epinephrine—Renal failure—Docetaxel—head and neck cancer	0.00157	0.00707	CcSEcCtD
Epinephrine—Myocardial infarction—Docetaxel—head and neck cancer	0.00157	0.00705	CcSEcCtD
Epinephrine—Chest pain—Fluorouracil—head and neck cancer	0.00147	0.00663	CcSEcCtD
Epinephrine—Haemoglobin—Docetaxel—head and neck cancer	0.00144	0.00649	CcSEcCtD
Epinephrine—Haemorrhage—Docetaxel—head and neck cancer	0.00144	0.00645	CcSEcCtD
Epinephrine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00143	0.00642	CcSEcCtD
Epinephrine—Dizziness—Vinblastine—head and neck cancer	0.00142	0.0064	CcSEcCtD
Epinephrine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00139	0.00623	CcSEcCtD
Epinephrine—Tachycardia—Fluorouracil—head and neck cancer	0.00138	0.0062	CcSEcCtD
Epinephrine—Vomiting—Vinblastine—head and neck cancer	0.00137	0.00615	CcSEcCtD
Epinephrine—Flushing—Docetaxel—head and neck cancer	0.00133	0.00599	CcSEcCtD
Epinephrine—Dizziness—Hydroxyurea—head and neck cancer	0.0013	0.00584	CcSEcCtD
Epinephrine—Arrhythmia—Docetaxel—head and neck cancer	0.00128	0.00577	CcSEcCtD
Epinephrine—Nausea—Vinblastine—head and neck cancer	0.00128	0.00575	CcSEcCtD
Epinephrine—Insomnia—Fluorouracil—head and neck cancer	0.00128	0.00575	CcSEcCtD
Epinephrine—Paraesthesia—Fluorouracil—head and neck cancer	0.00127	0.0057	CcSEcCtD
Epinephrine—Mental disorder—Docetaxel—head and neck cancer	0.00126	0.00565	CcSEcCtD
Epinephrine—Somnolence—Fluorouracil—head and neck cancer	0.00126	0.00565	CcSEcCtD
Epinephrine—Erythema—Docetaxel—head and neck cancer	0.00125	0.00562	CcSEcCtD
Epinephrine—Vomiting—Hydroxyurea—head and neck cancer	0.00125	0.00561	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00122	0.00548	CcSEcCtD
Epinephrine—Nausea—Hydroxyurea—head and neck cancer	0.00117	0.00524	CcSEcCtD
Epinephrine—Palpitations—Docetaxel—head and neck cancer	0.0011	0.00496	CcSEcCtD
Epinephrine—Hypertension—Docetaxel—head and neck cancer	0.00108	0.00485	CcSEcCtD
Epinephrine—Chest pain—Docetaxel—head and neck cancer	0.00106	0.00478	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00106	0.00475	CcSEcCtD
Epinephrine—Nervous system disorder—Docetaxel—head and neck cancer	0.001	0.0045	CcSEcCtD
Epinephrine—Tachycardia—Docetaxel—head and neck cancer	0.000995	0.00447	CcSEcCtD
Epinephrine—Skin disorder—Docetaxel—head and neck cancer	0.000991	0.00445	CcSEcCtD
Epinephrine—Dizziness—Fluorouracil—head and neck cancer	0.000934	0.0042	CcSEcCtD
Epinephrine—Insomnia—Docetaxel—head and neck cancer	0.000922	0.00415	CcSEcCtD
Epinephrine—Paraesthesia—Docetaxel—head and neck cancer	0.000916	0.00412	CcSEcCtD
Epinephrine—Somnolence—Docetaxel—head and neck cancer	0.000907	0.00408	CcSEcCtD
Epinephrine—Vomiting—Fluorouracil—head and neck cancer	0.000898	0.00404	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00088	0.00396	CcSEcCtD
Epinephrine—Nausea—Fluorouracil—head and neck cancer	0.000839	0.00377	CcSEcCtD
Epinephrine—Dizziness—Docetaxel—head and neck cancer	0.000674	0.00303	CcSEcCtD
Epinephrine—Vomiting—Docetaxel—head and neck cancer	0.000648	0.00292	CcSEcCtD
Epinephrine—Nausea—Docetaxel—head and neck cancer	0.000606	0.00272	CcSEcCtD
Epinephrine—ADRB3—Signaling Pathways—CCND1—head and neck cancer	5.81e-05	0.000164	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—CYP1A1—head and neck cancer	5.77e-05	0.000163	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—AKT1—head and neck cancer	5.75e-05	0.000162	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MAPK1—head and neck cancer	5.68e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—EGFR—head and neck cancer	5.68e-05	0.00016	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—YAP1—head and neck cancer	5.66e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NOTCH1—head and neck cancer	5.64e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—PTEN—head and neck cancer	5.61e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—AKT1—head and neck cancer	5.61e-05	0.000158	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL2—head and neck cancer	5.54e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—AKT1—head and neck cancer	5.47e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL2—head and neck cancer	5.46e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—IL2—head and neck cancer	5.34e-05	0.00015	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—MAPK3—head and neck cancer	5.29e-05	0.000149	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NAT2—head and neck cancer	5.25e-05	0.000148	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—AKT1—head and neck cancer	5.24e-05	0.000148	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—PIK3CA—head and neck cancer	5.21e-05	0.000147	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NOTCH1—head and neck cancer	5.14e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NOTCH1—head and neck cancer	5.1e-05	0.000144	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—VEGFA—head and neck cancer	5.07e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—head and neck cancer	5.04e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NOTCH1—head and neck cancer	5.03e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—MAPK1—head and neck cancer	5.03e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—EGFR—head and neck cancer	5.03e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—STAT3—head and neck cancer	5.02e-05	0.000141	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.98e-05	0.00014	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—IL2—head and neck cancer	4.96e-05	0.00014	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—PIK3CA—head and neck cancer	4.93e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL2—head and neck cancer	4.85e-05	0.000137	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—HRAS—head and neck cancer	4.82e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—MAPK3—head and neck cancer	4.82e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—PIK3CA—head and neck cancer	4.81e-05	0.000135	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MAPK3—head and neck cancer	4.79e-05	0.000135	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—MAPK3—head and neck cancer	4.77e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—head and neck cancer	4.77e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NOTCH1—head and neck cancer	4.76e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—MAPK3—head and neck cancer	4.71e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NOTCH1—head and neck cancer	4.68e-05	0.000132	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—DPYD—head and neck cancer	4.61e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—MAPK1—head and neck cancer	4.58e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—EGFR—head and neck cancer	4.58e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MAPK1—head and neck cancer	4.56e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—HRAS—head and neck cancer	4.56e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—EGFR—head and neck cancer	4.56e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—MAPK1—head and neck cancer	4.54e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—EGFR—head and neck cancer	4.54e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL2—head and neck cancer	4.5e-05	0.000127	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—MAPK1—head and neck cancer	4.48e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—EGFR—head and neck cancer	4.48e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—MAPK3—head and neck cancer	4.46e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—MAPK3—head and neck cancer	4.39e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—PIK3CA—head and neck cancer	4.38e-05	0.000123	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—YAP1—head and neck cancer	4.37e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—PIK3CA—head and neck cancer	4.36e-05	0.000123	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTGS2—head and neck cancer	4.34e-05	0.000122	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.34e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—PIK3CA—head and neck cancer	4.34e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—PIK3CA—head and neck cancer	4.28e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—AKT1—head and neck cancer	4.26e-05	0.00012	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.25e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—MAPK1—head and neck cancer	4.24e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—EGFR—head and neck cancer	4.24e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTGS2—head and neck cancer	4.23e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—MAPK1—head and neck cancer	4.17e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—EGFR—head and neck cancer	4.17e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NOTCH1—head and neck cancer	4.16e-05	0.000117	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—PIK3CA—head and neck cancer	4.05e-05	0.000114	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—head and neck cancer	4.05e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—HRAS—head and neck cancer	4.04e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—AKT1—head and neck cancer	4.03e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—PIK3CA—head and neck cancer	3.99e-05	0.000112	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—TYMS—head and neck cancer	3.98e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—PIK3CA—head and neck cancer	3.98e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—PIK3CA—head and neck cancer	3.96e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—PIK3CA—head and neck cancer	3.94e-05	0.000111	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GSTM1—head and neck cancer	3.93e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—AKT1—head and neck cancer	3.93e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—MAPK3—head and neck cancer	3.9e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—PIK3CA—head and neck cancer	3.89e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL2—head and neck cancer	3.88e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NOTCH1—head and neck cancer	3.87e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—head and neck cancer	3.83e-05	0.000108	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTEN—head and neck cancer	3.79e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCND1—head and neck cancer	3.79e-05	0.000107	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GPX1—head and neck cancer	3.77e-05	0.000106	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	3.73e-05	0.000105	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.71e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—MAPK1—head and neck cancer	3.71e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—EGFR—head and neck cancer	3.71e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTEN—head and neck cancer	3.69e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—PIK3CA—head and neck cancer	3.68e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—HRAS—head and neck cancer	3.68e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—HRAS—head and neck cancer	3.66e-05	0.000103	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PTEN—head and neck cancer	3.65e-05	0.000103	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—HRAS—head and neck cancer	3.65e-05	0.000103	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—PIK3CA—head and neck cancer	3.62e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—MAPK3—head and neck cancer	3.62e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—HRAS—head and neck cancer	3.6e-05	0.000101	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—AKT1—head and neck cancer	3.58e-05	0.000101	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—AKT1—head and neck cancer	3.56e-05	0.0001	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—AKT1—head and neck cancer	3.54e-05	9.98e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—PIK3CA—head and neck cancer	3.54e-05	9.98e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL2—head and neck cancer	3.54e-05	9.97e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTEN—head and neck cancer	3.53e-05	9.95e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL2—head and neck cancer	3.51e-05	9.88e-05	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—AKT1—head and neck cancer	3.5e-05	9.86e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL2—head and neck cancer	3.46e-05	9.75e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCND1—head and neck cancer	3.45e-05	9.72e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	3.44e-05	9.7e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	3.44e-05	9.7e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—head and neck cancer	3.43e-05	9.67e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCND1—head and neck cancer	3.42e-05	9.63e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—HRAS—head and neck cancer	3.4e-05	9.59e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—TYMS—head and neck cancer	3.4e-05	9.58e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCND1—head and neck cancer	3.37e-05	9.51e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GSTM1—head and neck cancer	3.36e-05	9.47e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—HRAS—head and neck cancer	3.35e-05	9.44e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PTEN—head and neck cancer	3.33e-05	9.38e-05	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AKT1—head and neck cancer	3.31e-05	9.33e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—head and neck cancer	3.3e-05	9.3e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PTEN—head and neck cancer	3.3e-05	9.29e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	3.29e-05	9.27e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2—head and neck cancer	3.28e-05	9.23e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—STAT3—head and neck cancer	3.27e-05	9.21e-05	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AKT1—head and neck cancer	3.26e-05	9.18e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PTEN—head and neck cancer	3.26e-05	9.18e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AKT1—head and neck cancer	3.25e-05	9.15e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKT1—head and neck cancer	3.23e-05	9.11e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2—head and neck cancer	3.22e-05	9.08e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GPX1—head and neck cancer	3.22e-05	9.07e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AKT1—head and neck cancer	3.22e-05	9.07e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	3.22e-05	9.06e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCND1—head and neck cancer	3.19e-05	8.99e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	3.19e-05	8.98e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AKT1—head and neck cancer	3.18e-05	8.95e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCND1—head and neck cancer	3.14e-05	8.85e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MAPK3—head and neck cancer	3.12e-05	8.8e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PTEN—head and neck cancer	3.08e-05	8.68e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.06e-05	8.63e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	3.03e-05	8.54e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—head and neck cancer	3.01e-05	8.47e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AKT1—head and neck cancer	3.01e-05	8.47e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTEN—head and neck cancer	2.99e-05	8.43e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	2.99e-05	8.42e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—head and neck cancer	2.98e-05	8.39e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—STAT3—head and neck cancer	2.98e-05	8.39e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	2.98e-05	8.39e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MAPK1—head and neck cancer	2.97e-05	8.37e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EGFR—head and neck cancer	2.97e-05	8.37e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	2.96e-05	8.34e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—STAT3—head and neck cancer	2.95e-05	8.31e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—head and neck cancer	2.94e-05	8.29e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—STAT3—head and neck cancer	2.91e-05	8.21e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	2.89e-05	8.15e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2—head and neck cancer	2.86e-05	8.07e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MAPK3—head and neck cancer	2.84e-05	8.01e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MAPK3—head and neck cancer	2.82e-05	7.94e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	2.79e-05	7.86e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—head and neck cancer	2.78e-05	7.84e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MAPK3—head and neck cancer	2.78e-05	7.84e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	2.77e-05	7.79e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—STAT3—head and neck cancer	2.76e-05	7.76e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	2.74e-05	7.72e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	2.71e-05	7.64e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MAPK1—head and neck cancer	2.71e-05	7.63e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EGFR—head and neck cancer	2.71e-05	7.62e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	2.69e-05	7.59e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	2.69e-05	7.58e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MAPK1—head and neck cancer	2.68e-05	7.56e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EGFR—head and neck cancer	2.68e-05	7.55e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PIK3CA—head and neck cancer	2.67e-05	7.53e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2—head and neck cancer	2.66e-05	7.49e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MAPK1—head and neck cancer	2.65e-05	7.46e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EGFR—head and neck cancer	2.65e-05	7.46e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MAPK3—head and neck cancer	2.63e-05	7.42e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	2.63e-05	7.4e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—TYMS—head and neck cancer	2.62e-05	7.39e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.62e-05	7.37e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PIK3CA—head and neck cancer	2.6e-05	7.32e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.59e-05	7.31e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	2.59e-05	7.31e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	2.59e-05	7.3e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PIK3CA—head and neck cancer	2.58e-05	7.26e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MAPK1—head and neck cancer	2.51e-05	7.06e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EGFR—head and neck cancer	2.5e-05	7.06e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	2.5e-05	7.05e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—head and neck cancer	2.49e-05	7.03e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PIK3CA—head and neck cancer	2.49e-05	7.02e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GPX1—head and neck cancer	2.48e-05	7e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	2.47e-05	6.95e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	2.47e-05	6.95e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.46e-05	6.93e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	2.44e-05	6.88e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	2.43e-05	6.86e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	2.41e-05	6.79e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HRAS—head and neck cancer	2.39e-05	6.72e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PIK3CA—head and neck cancer	2.35e-05	6.62e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PIK3CA—head and neck cancer	2.33e-05	6.56e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	2.3e-05	6.48e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PIK3CA—head and neck cancer	2.3e-05	6.47e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—head and neck cancer	2.27e-05	6.4e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	2.26e-05	6.37e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—head and neck cancer	2.25e-05	6.34e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	2.24e-05	6.31e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—head and neck cancer	2.22e-05	6.26e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—head and neck cancer	2.22e-05	6.25e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	2.19e-05	6.17e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	2.19e-05	6.17e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AKT1—head and neck cancer	2.18e-05	6.15e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PIK3CA—head and neck cancer	2.17e-05	6.12e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HRAS—head and neck cancer	2.17e-05	6.12e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HRAS—head and neck cancer	2.15e-05	6.07e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	2.14e-05	6.03e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	2.14e-05	6.03e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HRAS—head and neck cancer	2.13e-05	5.99e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AKT1—head and neck cancer	2.12e-05	5.98e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PIK3CA—head and neck cancer	2.11e-05	5.95e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKT1—head and neck cancer	2.11e-05	5.93e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—head and neck cancer	2.1e-05	5.93e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—head and neck cancer	2.07e-05	5.83e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AKT1—head and neck cancer	2.04e-05	5.73e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	2.03e-05	5.73e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	2.03e-05	5.73e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HRAS—head and neck cancer	2.01e-05	5.67e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	1.98e-05	5.58e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTEN—head and neck cancer	1.93e-05	5.45e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKT1—head and neck cancer	1.92e-05	5.41e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKT1—head and neck cancer	1.9e-05	5.36e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	1.9e-05	5.35e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.89e-05	5.34e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKT1—head and neck cancer	1.88e-05	5.29e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—head and neck cancer	1.84e-05	5.18e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKT1—head and neck cancer	1.78e-05	5e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	1.77e-05	4.97e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	1.76e-05	4.95e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	1.75e-05	4.92e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AKT1—head and neck cancer	1.73e-05	4.86e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—head and neck cancer	1.71e-05	4.81e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTEN—head and neck cancer	1.65e-05	4.66e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	1.63e-05	4.6e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	1.55e-05	4.37e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.46e-05	4.12e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	1.44e-05	4.06e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.36e-05	3.84e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTEN—head and neck cancer	1.28e-05	3.59e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.17e-05	3.28e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AKT1—head and neck cancer	1.11e-05	3.14e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKT1—head and neck cancer	9.52e-06	2.68e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	9e-06	2.53e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKT1—head and neck cancer	7.35e-06	2.07e-05	CbGpPWpGaD
